B9P Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - NovaBay Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 2.8 EUR Market Closed

Market Cap: €11.8m

	NovaBay Pharmaceuticals Inc F:B9P	US
	SNT Motiv Co Ltd KRX:064960	KR
	Teqnion AB F:M45	SE
	Leonardo SpA F:FMN	IT
	FieldPoint Petroleum Corp OTC:FPPP	US
	Eureka Group Holdings Ltd ASX:EGH	AU
D	Depo Auto Parts Industrial Co Ltd TWSE:6605	TW
F	FirstRand Ltd SWB:FSRA	ZA

Profitability Summary

NovaBay Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Sustainable 3Y Average Gross Margin

37%

Exceptional Operating Margin

58%

Negative 3Y Average Operating Margin

-122%

Operating Margin is Increasing

-85% > 58%

Exceptional Net Margin

1 735%

Negative 3Y Average Net Margin

-267%

Net Margin is Increasing

-130% > 1 735%

Negative Free Cash Flow Margin

-3%

Strong 3Y Average Free Cash Flow Margin

29%

Free Cash Flow Margin is Increasing

-42% > -3%

Exceptional ROE

735%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-121%

ROIC is Increasing

-97% > 26%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.